Skip to content

ERS LAB: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

ERS LAB

BE 1009.056.158
NACE 86.910, Medical imaging and medical laboratories
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€3,488
2024 · €9,857-€6,369
Equity
€17,845
2024 · €9,857+€7,988
Cash
€1,111
2024 · €13+€1,098
Balance sheet total
€25,274
2024 · €10,256+€15,018

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€13,920

    up €13,920 (+135.9%), from €10,243 to €24,163

    of which Other amounts receivable: +€9,151

  • Cash +€1,098

    up €1,098 (+8398.9%), from €13 to €1,111

    mainly Tax, wage and social debts (+€6,393) and Contributions, distributions and other (+€4,500)

Equity and liabilities
  • Tax, wage and social debts +€6,393

    new in 2025: €6,393

    of which Remuneration and social security: +€5,277

  • Contributions +€4,500

    new in 2025: €4,500

  • Profit (loss) carried forward +€3,488

    up €3,488 (+35.4%), from €9,857 to €13,345

  • Trade debts +€637

    up €637 (+159.5%), from €399 to €1,037

Income statement
  • Staff costs +€27,293

    up €27,293 (+246.9%), from €11,057 to €38,350

  • Gross operating margin +€20,439

    up €20,439 (+97.7%), from €20,913 to €41,352

  • Financial income +€1,665

    new in 2025: €1,665

  • Taxes +€1,116

    new in 2025: €1,116

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €9,857
Gross operating margin +€20,439
Staff costs -€27,293
Financial income +€1,665
Financial charges -€64
Taxes -€1,116
Result 2025 €3,488

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€3,402
Investment €0
Financing +€4,500
Cash 2024 €13
Net result for the year +€3,488
Receivables within one year -€13,920
Trade debts +€637
Tax, wage and social debts +€6,393
Contributions, distributions and other +€4,500
Cash 2025 €1,111
Every line side by side 28 lines
Line Code 2024 2025 Change %
Total assets 20/58 €10,256 €25,274 +€15,018 +146.4%
Current assets 29/58 €10,256 €25,274 +€15,018 +146.4%
Amounts receivable within one year 40/41 €10,243 €24,163 +€13,920 +135.9%
Trade receivables 40 €1,530 €6,299 +€4,769 +311.7%
Other amounts receivable 41 €8,713 €17,865 +€9,151 +105.0%
Cash at bank and in hand 54/58 €13 €1,111 +€1,098 +8398.9%
Total equity and liabilities 10/49 €10,256 €25,274 +€15,018 +146.4%
Equity 10/15 €9,857 €17,845 +€7,988 +81.0%
Contributions 10/11 - €4,500 +€4,500
Profit (loss) carried forward 14 €9,857 €13,345 +€3,488 +35.4%
Amounts payable 17/49 €399 €7,430 +€7,030 +1760.0%
Amounts payable within one year 42/48 €399 €7,430 +€7,030 +1760.0%
Trade debts 44 €399 €1,037 +€637 +159.5%
Suppliers 440/4 €399 €1,037 +€637 +159.5%
Taxes, remuneration and social security 45 - €6,393 +€6,393
Taxes 450/3 - €1,116 +€1,116
Remuneration and social security 454/9 - €5,277 +€5,277
Remuneration, social security and pensions 62 €11,057 €38,350 +€27,293 +246.9%
Gross operating margin 9900 €20,913 €41,352 +€20,439 +97.7%
Operating profit (loss) 9901 €9,857 €3,002 -€6,855 -69.5%
Financial income 75/76B - €1,665 +€1,665
Recurring financial income 75 - €1,665 +€1,665
Financial charges 65/66B - €64 +€64
Recurring financial charges 65 - €64 +€64
Profit (loss) for the period before taxes 9903 €9,857 €4,603 -€5,254 -53.3%
Income taxes 67/77 - €1,116 +€1,116
Profit (loss) for the period 9904 €9,857 €3,488 -€6,369 -64.6%
Profit (loss) for the period to be appropriated 9905 €9,857 €3,488 -€6,369 -64.6%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.